 Home > Active Ingredient News > Study of Nervous System > NMPA approves Phase III clinical trials of 18F-APN-1607 Tau PET imaging tracer for dementia

NMPA approves Phase III clinical trials of 18F-APN-1607 Tau PET imaging tracer for dementia

 Last Update: 2020-11-06
 Source: Internet
 Author: User

Tags

hiv clinical trials

phase 4 trial

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

APRINOIA Therapeutics announced today that China's State Drug Administration (NMPA) has approved the launch of Phase III clinical trials to evaluate APRINOIA's positive electron emission fault scanning (PET) imaging tracer 18F-APN-1607, which targets abnormal tau protein aggregations in the brains of patients with cognitive impairment.
18F-APN-1607 is a next-generation tau PET imaging tracer with improved selectivity and off-target binding spectrum.
it is designed to specifically identify tau proteins in pathological aggregation, but does not recognize normal tau proteins.
the purpose of this Phase III clinical trial is to assess the safety and effectiveness of 18F-APN-1607 in distinguishing between mild cognitive impairment (MCI) and alzheimer's disease (AD) at different stages.
the trial will recruit about 230 subjects, all of them 18F-APN-1607.
Tzu-Chen Yen, China director of APRANOIA, said: "We are pleased that 18F-APN-1607 is an important step towards commercialization.
diagnosis is the basis for an effective treatment plan for neurodegenerative diseases.
our goal is to provide 18F-APN-1607 access nationwide in the future for accurate diagnosis."

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pregabalin 99% powder 148553-50-8 -Shaanxi Dideu Medichem Co.Ltd

CAS No.: 148553-50-8

Chemical Grade

$1/KG FOB

Pregabalin (CNS)

CAS No.: 148553-50-8

Pharmacy Grade

$1/KG FOB

Primidone CAS125-33-7

CAS No.: 125-33-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.